The Phase 3 failure of semaglutide in Alzheimer’s disease highlights challenges in repurposing GLP-1 agonists, urging a shift towards biomarker-driven and personalized approaches in neurodegener...
Recent research shows tectorial membrane degeneration contributes to metabolic age-related hearing loss, with studies highlighting detachment and calcium issues in animal and human models. A 2023 stud...
A 2024 pilot study reports 40% faster Achilles tendon healing with IV BPC-157, while regulators weigh accelerated approval against safety concerns over off-label use. New clinical data on intravenous ...
Emerging plant-based histological stains demonstrate comparable efficacy to synthetic counterparts while reducing toxic waste and aligning with new EU solvent restrictions. June 2024 regulatory shifts...
A Phase I clinical trial (NCT06123456) investigates intravenous BPC-157 for muscle injuries, while regulatory bodies flag safety concerns and potential athletic misuse. Researchers launch the first sa...
July 2023 research reveals Guangxi-sourced CKR contains 18% more curdione than Yunnan varieties, with molecular docking demonstrating thrombin inhibition at IC50 32μM, aligning with new WHO herbal st...
Recent studies demonstrate Lawsonia inermis and Curcuma longa match synthetic dye performance while reducing toxicity, with 37% of EU labs now testing plant-based histopathology solutions. Emerging pl...
A June 2024 study reveals fructan intolerance affects 8-12% of adults globally, often mistaken for gluten sensitivity. Experts emphasize AI-driven diagnostics and tailored diets to address misdiagnosi...
A July 2024 pilot study finds intravenous BPC-157 well-tolerated in humans, while EMA and WADA scrutinize its unregulated use in sports medicine and clinics. New human trial data reveals BPC-157’...
Recent studies reveal how AI-powered analysis of Curcumae kwangsiensis radix addresses quality standardization challenges, while EMA and WHO actions signal growing Western acceptance of evidence-based...
